Earl J Hope, MD | |
301 S 7th Ave, Suite 2020, West Reading, PA 19611-1410 | |
(610) 375-6565 | |
(610) 375-2065 |
Full Name | Earl J Hope |
---|---|
Gender | Male |
Speciality | Interventional Cardiology |
Experience | 37 Years |
Location | 301 S 7th Ave, West Reading, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043299480 | NPI | - | NPPES |
001510715 | Medicaid | PA |
Facility Name | Location | Facility Type |
---|---|---|
Reading Hospital | West reading, PA | Hospital |
St Joseph Medical Center | Reading, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Tower Health Medical Group | 7618889213 | 577 |
News Archive
Sometimes it can be difficult to understand people talking about cancer, especially doctors, scientists, and reporters. Part of the reason is because they use so many numbers and statistics without explaining exactly what they mean. A famous philosopher once said that "Mathematics is the language of science." But most of us don't speak that language very well. Here are some ways to think about the numbers that professionals may use when talking about cancer.
A study published in the August issue of Cancer Research has resulted in several premature and potentially misleading conclusions when it comes to fructose and its effect on pancreatic tumor cells. Unfortunately, the media covering this story, and even the authors, have been too quick to extrapolate the results of laboratory research on pure fructose to real-world conditions, which is not appropriate or helpful to consumers.
The National Institutes of Health is launching a large multicenter randomized clinical trial to determine whether maintaining blood pressure levels lower than current recommendations further reduces the risk of cardiovascular and kidney diseases, or age-related cognitive decline.
ImmunoCellular Therapeutics, Ltd. today announced the establishment of an agreement with Novella Clinical (Novella), to conduct the phase 3 registration trial of ICT-107 in patients with newly diagnosed glioblastoma. Novella is a full-service, global clinical research organization (CRO) providing clinical trial services to small to mid-sized oncology companies.
› Verified 3 days ago
Entity Name | Tower Health Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609291350 PECOS PAC ID: 7618889213 Enrollment ID: O20040311000072 |
News Archive
Sometimes it can be difficult to understand people talking about cancer, especially doctors, scientists, and reporters. Part of the reason is because they use so many numbers and statistics without explaining exactly what they mean. A famous philosopher once said that "Mathematics is the language of science." But most of us don't speak that language very well. Here are some ways to think about the numbers that professionals may use when talking about cancer.
A study published in the August issue of Cancer Research has resulted in several premature and potentially misleading conclusions when it comes to fructose and its effect on pancreatic tumor cells. Unfortunately, the media covering this story, and even the authors, have been too quick to extrapolate the results of laboratory research on pure fructose to real-world conditions, which is not appropriate or helpful to consumers.
The National Institutes of Health is launching a large multicenter randomized clinical trial to determine whether maintaining blood pressure levels lower than current recommendations further reduces the risk of cardiovascular and kidney diseases, or age-related cognitive decline.
ImmunoCellular Therapeutics, Ltd. today announced the establishment of an agreement with Novella Clinical (Novella), to conduct the phase 3 registration trial of ICT-107 in patients with newly diagnosed glioblastoma. Novella is a full-service, global clinical research organization (CRO) providing clinical trial services to small to mid-sized oncology companies.
› Verified 3 days ago
Entity Name | Phoenixville Clinic Company Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891866182 PECOS PAC ID: 5799796850 Enrollment ID: O20060606000128 |
News Archive
Sometimes it can be difficult to understand people talking about cancer, especially doctors, scientists, and reporters. Part of the reason is because they use so many numbers and statistics without explaining exactly what they mean. A famous philosopher once said that "Mathematics is the language of science." But most of us don't speak that language very well. Here are some ways to think about the numbers that professionals may use when talking about cancer.
A study published in the August issue of Cancer Research has resulted in several premature and potentially misleading conclusions when it comes to fructose and its effect on pancreatic tumor cells. Unfortunately, the media covering this story, and even the authors, have been too quick to extrapolate the results of laboratory research on pure fructose to real-world conditions, which is not appropriate or helpful to consumers.
The National Institutes of Health is launching a large multicenter randomized clinical trial to determine whether maintaining blood pressure levels lower than current recommendations further reduces the risk of cardiovascular and kidney diseases, or age-related cognitive decline.
ImmunoCellular Therapeutics, Ltd. today announced the establishment of an agreement with Novella Clinical (Novella), to conduct the phase 3 registration trial of ICT-107 in patients with newly diagnosed glioblastoma. Novella is a full-service, global clinical research organization (CRO) providing clinical trial services to small to mid-sized oncology companies.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Earl J Hope, MD Po Box 13579, Reading, PA 19612-3579 Ph: (484) 628-0796 | Earl J Hope, MD 301 S 7th Ave, Suite 2020, West Reading, PA 19611-1410 Ph: (610) 375-6565 |
News Archive
Sometimes it can be difficult to understand people talking about cancer, especially doctors, scientists, and reporters. Part of the reason is because they use so many numbers and statistics without explaining exactly what they mean. A famous philosopher once said that "Mathematics is the language of science." But most of us don't speak that language very well. Here are some ways to think about the numbers that professionals may use when talking about cancer.
A study published in the August issue of Cancer Research has resulted in several premature and potentially misleading conclusions when it comes to fructose and its effect on pancreatic tumor cells. Unfortunately, the media covering this story, and even the authors, have been too quick to extrapolate the results of laboratory research on pure fructose to real-world conditions, which is not appropriate or helpful to consumers.
The National Institutes of Health is launching a large multicenter randomized clinical trial to determine whether maintaining blood pressure levels lower than current recommendations further reduces the risk of cardiovascular and kidney diseases, or age-related cognitive decline.
ImmunoCellular Therapeutics, Ltd. today announced the establishment of an agreement with Novella Clinical (Novella), to conduct the phase 3 registration trial of ICT-107 in patients with newly diagnosed glioblastoma. Novella is a full-service, global clinical research organization (CRO) providing clinical trial services to small to mid-sized oncology companies.
› Verified 3 days ago
Ankush Lahoti, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave, Suite 2020, West Reading, PA 19611 Phone: 610-375-6565 Fax: 610-375-2065 | |
Tayyab Ali Waheed, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8640 Fax: 484-628-9003 | |
Nyein Yu, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-5455 | |
Richard Loynd, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 6th Avenue And Spruce Street, West Reading, PA 19611 Phone: 484-628-8640 Fax: 484-628-9003 | |
Krysta Brown, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave Ste 340, West Reading, PA 19611 Phone: 484-628-8640 Fax: 484-628-9003 | |
Niranjan Tachamo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-5455 |